O&G SAQs · Neonatal care — bilirubin metabolism
Neonatal jaundice — structured SAQ (15 marks)
FRANZCOG-format structured SAQ on haemolytic neonatal jaundice (Rh isoimmunisation): classification, nomogram-based threshold management, the work-up for haemolysis, the role of intravenous immunoglobulin and exchange transfusion, and the communication with an anxious parent. Per-sub-part marking rubric included.
On this page
Study tools
Target exams
How this SAQ is marked
Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks come from specifics: the timing classification, the nomogram framework named, the work-up sent, and the adjuncts used. Write in short labelled points, not prose paragraphs. [1]
Reveal model answer and mark schemeShowHide
(a) Classification (2 marks)
One mark for the classification, one for the rationale. [1][3]
- Pathological, unconjugated, haemolytic jaundice of immune origin (Rh isoimmunisation). Onset within the first 24 hours, a rapid rise (over 12 micromoles per litre per hour), a positive direct antiglobulin test and a reticulocytosis all confirm an immune haemolytic process.
- The classification matters because it places this infant on the lower (risk-factor) threshold line of the nomogram, not the standard line.[1]
(b) Initial management and threshold framework (4 marks)
One mark per named step. [1][2]
- Plot the bilirubin against postnatal age in hours on the gestational-age-stratified nomogram (AAP 2022 / NICE CG98 / Queensland Clinical Guidelines), applying the lower risk-factor threshold line because of haemolysis. A single number without the timing and the nomogram is meaningless.[1]
- Intensive phototherapy now. The bilirubin is at the phototherapy threshold with haemolysis and a rapid rise; intensive phototherapy with high irradiance and a close light source is the first intervention.
- Hydration, warmth and feeding — phototherapy increases insensible losses; supplement feeding as needed; keep the infant warm.[3]
- Recheck the bilirubin within 2 to 3 hours of starting phototherapy to confirm the trajectory is falling.[1]
(c) Investigations to confirm the underlying cause (3 marks)
One mark per investigation. [1][3]
- Maternal blood group and antibody screen, infant blood group and direct antiglobulin test — confirms immune haemolysis and identifies the antibody.
- Full blood count with reticulocyte count — reticulocytosis confirms active haemolysis; haemoglobin trajectory guides transfusion decisions.
- G6PD assay — coexisting G6PD deficiency changes both the trajectory and the trigger avoidance advice.[3]
- Albumin — a low albumin (under 30 g per litre) lowers the threshold and supports the case for exchange.
(d) Continued rise despite intensive phototherapy (3 marks)
- Intravenous immunoglobulin — indicated in immune-mediated haemolysis when the bilirubin continues to rise despite intensive phototherapy, with the aim of reducing the exchange rate.[1]
- Prepare for exchange transfusion. Indicated if the bilirubin reaches the exchange threshold despite intensive phototherapy and IVIG, or at the first sign of acute bilirubin encephalopathy (lethargy, hypertonia, high-pitched cry).[1]
- Acknowledge complications of exchange — thrombocytopenia, electrolyte disturbance, necrotising enterocolitis, and serious adverse events in a small minority; the decision is reserved for genuine threshold-crossing, not for marginal elevation.[5]
(e) Communication (3 marks)
Scored against the rapport and communication domains. [1]
- Plain language, no jargon: "Your baby's blood type and yours are not compatible in a way that has caused some of his red cells to break down faster than usual. That makes a substance called bilirubin, which is what makes him yellow. We are treating him with special lights to bring the level down. If the level keeps rising, we have other treatments ready."[1]
- Acknowledge fear directly: "I know the word 'brain damage' is frightening. We are watching his level very closely and treating aggressively to keep it in a safe range. We will keep you informed at every step."
- Commit to a follow-up plan, a named person to ask questions of, and a debrief once the picture stabilises.
References5ShowHide
- [1]Kemper AR, Newman TB, Slaughter JL, et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation Pediatrics, 2022.PMID 35927462
- [2]Wickremasinghe AC, Kuzniewicz MW Neonatal Hyperbilirubinemia Pediatr Clin North Am, 2025.PMID 40619190
- [3]Bhutani VK, Maisels MJ, Stark AR, et al. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants ≥35 weeks gestation Neoreviews, 2008.PMID 18204221
- [4]Watchko JF, Maisels MJ The enigma of low bilirubin kernicterus in premature infants: why does it still occur, and is it preventable? Semin Perinatol, 2014.PMID 25267279
- [5]Patra K, Storfer-Isser A, Siner B, et al. Adverse events associated with neonatal exchange transfusion in the 1990s J Pediatr, 2004.PMID 15126997